Actionable news
All posts from Actionable news
Actionable news in BMY: BRISTOL-MYERS SQUIBB CO.,

Bristol-Myers Squibb (BMY) Giovanni Caforio on Q3 2015 Results - Earnings Call Transcript


Good morning, my name is Jonathan, and I will be your conference operator today. At this time I would like to welcome everyone to the Bristol-Myers 2015 third quarter results conference call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session.

Thank you. Mr. John Elicker, Vice President of Investor Relations and Public Affairs, you may begin your conference.

John E. Elicker - Senior Vice President, Public Affairs & Investor Relations

Thanks, Jonathan, and good morning, everybody. I know it's been a busy day, so we do appreciate you joining us for today's call to review our third quarter results. With me this morning is Giovanni Caforio, our CEO; Charlie Bancroft, our CFO. They will both have prepared remarks. And then joining for Q&A as well will be Francis Cuss, our Chief Scientific Officer, and Murdo Gordon, our Head of Worldwide Markets.

Before I turn it over to Giovanni, let me take care of the Safe Harbor language: During the call we will make statements about the company's future plans and prospects that constitute...